112 related articles for article (PubMed ID: 35217239)
1. Retraction notice to "MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway" [J. Reprod. Immunol. 143C (2021) 103265].
Wang C; Kuang L; Han L
J Reprod Immunol; 2022 Mar; 150():103498. PubMed ID: 35217239
[No Abstract] [Full Text] [Related]
2. MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway.
Wang C; Kuang L; Han L
J Reprod Immunol; 2021 Feb; 143():103265. PubMed ID: 33360511
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" [J. Reprod. Immunol. 140C (2020) 103129].
Qiao HF; Liu YL; You J; Zheng YL; Chen LP; Lu XY; Du L; Shan F; Liu MH
J Reprod Immunol; 2022 Mar; 150():103495. PubMed ID: 35219213
[No Abstract] [Full Text] [Related]
4. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.
Huang F; Wang B; Zeng J; Sang S; Lei J; Lu Y
Oncol Lett; 2018 Apr; 15(4):4797-4804. PubMed ID: 29552119
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "Interplay of microRNAs to genetic, epigenetic, copy number variations of cervical cancer related genes" [J. Reprod. Immunol. 142C (2020) 103184].
Dai J; Wang L; Li L; Tian X; Shang Z; Li H
J Reprod Immunol; 2022 Mar; 150():103496. PubMed ID: 35217237
[No Abstract] [Full Text] [Related]
6. Retraction notice to "Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC" [J. Reprod. Immunol. 145C (2021) 103310].
Alrashed MM; Ahmad M; Yongmei W; Xiuyeng W
J Reprod Immunol; 2022 Mar; 150():103497. PubMed ID: 35217238
[No Abstract] [Full Text] [Related]
7. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
[TBL] [Abstract][Full Text] [Related]
8. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.
Zhou ZQ; Zhao JJ; Pan QZ; Chen CL; Liu Y; Tang Y; Zhu Q; Weng DS; Xia JC
J Immunother Cancer; 2019 Aug; 7(1):228. PubMed ID: 31455411
[TBL] [Abstract][Full Text] [Related]
10. MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.
Xia N; Tan WF; Peng QZ; Cai HN
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):513-521. PubMed ID: 30720158
[TBL] [Abstract][Full Text] [Related]
11. Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.
Zhang L; Wang J; Wei F; Wang K; Sun Q; Yang F; Jin H; Zheng Y; Zhao H; Wang L; Yu W; Zhang X; An Y; Yang L; Zhang X; Ren X
Oncotarget; 2016 Jul; 7(28):43604-43615. PubMed ID: 27283895
[TBL] [Abstract][Full Text] [Related]
12. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Dong P; Xiong Y; Yu J; Chen L; Tao T; Yi S; Hanley SJB; Yue J; Watari H; Sakuragi N
Oncogene; 2018 Sep; 37(39):5257-5268. PubMed ID: 29855617
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
Qu R; Hao S; Jin X; Shi G; Yu Q; Tong X; Guo D
Gene; 2018 Feb; 642():354-361. PubMed ID: 29128635
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients.
Li J; Zhang X; Tang J; Gong C
Onco Targets Ther; 2020; 13():4229-4237. PubMed ID: 32523358
[TBL] [Abstract][Full Text] [Related]
15. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X
Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Chen CL; Pan QZ; Zhao JJ; Wang Y; Li YQ; Wang QJ; Pan K; Weng DS; Jiang SS; Tang Y; Zhang XF; Zhang HX; Zhou ZQ; Zeng YX; Xia JC
Oncoimmunology; 2016 Jul; 5(7):e1176653. PubMed ID: 27622026
[TBL] [Abstract][Full Text] [Related]
17. PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines.
Li Y; Sharma A; Bloemendal MWJR; Schmidt-Wolf R; Kornek M; Schmidt-Wolf IGH
Oncol Lett; 2021 Aug; 22(2):613. PubMed ID: 34257721
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
Zhang Y; Qiu S; Guo Y; Zhang J; Wu X; Hong G
Technol Cancer Res Treat; 2021; 20():1533033821995281. PubMed ID: 33632085
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer-associated transcript 1 promotes melanoma cell proliferation and invasion via the miR-374b-5p/U2-associated factor homology motif kinase 1 axis.
Wu ZZ; Xu Q
Kaohsiung J Med Sci; 2022 Feb; 38(2):97-107. PubMed ID: 34708547
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.
Li J; Chen L; Xiong Y; Zheng X; Xie Q; Zhou Q; Shi L; Wu C; Jiang J; Wang H
Cell Physiol Biochem; 2017; 41(3):907-920. PubMed ID: 28222426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
